Aclarion, Inc.
ACON- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- SEC CIK
- 0001635077
In the last 90 days, Aclarion, Inc. insiders filed 6 open-market purchases and 0 sales; 15 institutions reported holding it in 13F filings for Q2 2026, worth $332.1K in total; no superinvestor holds it.
Other share classesACONW
Q2 2022 vs. Q1 2022
How the institutions holding Aclarion, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Q2 2022 | Change |
|---|---|---|---|
| Holders | 0 | 3 | +3 |
| Shares | 0 | 72.4K | +72.4K |
| Value | $0 | $66.0K | +$66.0K |
New holders (3)
Institutions that held Aclarion, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Frontier Wealth Management LLC | 64,400 | $59.0K | 0.00% |
| UBS Group AG | 7,965 | $7.00K | 0.00% |
| Wells Fargo & Company | 15 | $0 | 0.00% |
Sold out (0)
Institutions that held Aclarion, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
None.